El caso de Singulair, un medicamento para el asma que provocó angustianews2024-01-17T13:18:21+00:00January 17th, 2024|The New York Times|
F.D.A. Warned of Mental Side Effects from Asthma Drug, Singulair. Few Were Told.news2024-01-09T10:03:02+00:00January 9th, 2024|The New York Times|
El Paxlovid reduce el riesgo de muerte por covid, pero no todos los que lo necesitan lo tomannews2024-01-06T00:00:08+00:00January 6th, 2024|The New York Times|
F.D.A. to Issue First Approval for Mass Drug Imports to States from Canadanews2024-01-05T18:06:59+00:00January 5th, 2024|The New York Times|
Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.news2024-01-04T17:15:07+00:00January 4th, 2024|The New York Times|
We Need to Rethink Our Treatment of Painnews2023-12-24T14:00:21+00:00December 24th, 2023|The New York Times|
This Quiet Blockbuster at the Supreme Court Could Impact All Americansnews2023-11-22T13:46:34+00:00November 22nd, 2023|The New York Times|
Amazon to Stop Selling Seven Eyedrops After F.D.A. Warningnews2023-11-15T16:16:27+00:00November 15th, 2023|The New York Times|
Eyedrops From Major Brands May Cause Infection, F.D.A. Saysnews2023-10-29T23:47:48+00:00October 29th, 2023|The New York Times|
